To print: Select File and then Print from your browser's menu

Title: Oxandrolone Aids Weight Restoration in Chronic Obstructive Pulmonary Disease

URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=R
Retrieve&db=PubMed&list_uids=12171812&dopt=Abstract

Chest 2002, 122(2):421-8 "Reversal of COPD-Associated Weight Loss Using the Anabolic Agent Oxandrolone(*)."
08/26/2002 03:37:19 PM
By David Ball

Patients who experience weight loss associated with chronic obstructive pulmonary disease (COPD) can be helped to restore weight with the anabolic agent oxandrolone, say United States researchers. Since oxandrolone is well tolerated in such patients, this effective adjunct should be considered in their comprehensive management, suggest Dr S.S.Yeh and colleagues at the Veterans' Affairs Medical Center, Northport, New York. While negative outcomes are associated with weight loss common in COPD, improved outcomes are associated with weight gain which was found to be primarily lean body mass. In this prospective open-label clinical trial, COPD patients in 25 community based US pulmonary practices were evaluated on the effects of oral oxandrolone, 10 mg [b.i.d. Moderate-to-severe COPD in a primary pulmonary diagnosis was defined by FEV₁ of less than 50 percent of predicted and FEV₁/FVC ratio less than 0.7, as well as significant involuntary weight loss (weight

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=R
Retrieve&db=PubMed&list_uids=12171812&dopt=Abstract

Copyright Š 2009 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content.